Synthetic cannabinoids and bleeding multistate outbreak tops 200 cases
by News Desk from Outbreak News Today on (#3RHW3)
The Centers for Disease Control and Prevention (CDC) is currently coordinating national surveillance activities for possible cases of vitamin K-dependent antagonist coagulopathy associated with synthetic cannabinoids use. Since the index case was identified in Illinois on March 3, 2018, state health departments have reported 202 cases, including five deaths. Case patients have been identified in ["]
The post Synthetic cannabinoids and bleeding multistate outbreak tops 200 cases appeared first on Outbreak News Today.